Mahindra Manulife Mid Cap IDCW Payout Direct Plan
SIP amount
Min. ₹500
Lumpsum amount
Min. ₹1,000

Mahindra Manulife Mid Cap IDCW Payout Direct Plan

NAV
₹30.5799
-0.57%
(4 Nov)
AUM
3,994 Cr
TER
0.46%
Risk
Very High Risk
Rating
Insights
Total Expense Ratio (TER) is in the bottom 25% of comparable funds
Net Asset Value (NAV) is below its 200 days moving average
In beta. Send feedback here.
Compare with other fund
1Y
+14.5%
+14.5%
+10.9%
+10.9%
+5.8%
+3.4%
3Y
+28.6%
+28.6%
+27.1%
+27.1%
+21.9%
+25.2%
5Y
+29.7%
+29.7%
NA
NA
+26.0%
+29.4%
ALL
+21.1%
+21.1%
+26.7%
+26.4%
+17.2%
+18.8%
VOL
17.6%
17.6%
14.6%
14.6%
-
17.5%
TER
0.5%
0.5%
0.5%
0.5%
-
0.5%
AUM
₹8,518 Cr
₹8,518 Cr
₹3,731 Cr
₹3,731 Cr
-
₹3,994 Cr
INFO
1.20
1.20
1.83
1.81
-
1.08
Past performance
Past performance is no guarantee of future returns.
Had you invested
Over the last
1Y
3Y
ALL
Your returns would have been
Mahindra Manulife Mid Cap IDCW Payout (DP)
₹1,00,00,00,000
14.0%
Fixed deposit
₹40,00,00,000
6.0%
Bank savings
₹40,00,00,000
3.0%
See fund holdings as of 30th Sep
Top holdings
Glenmark Pharmaceuticals Ltd
3.1%
Indian Bank
3.0%
UNO Minda Ltd
2.6%
Blue Star Ltd
2.5%
Tube Investments of India Ltd Ordinary Shares
2.4%
Nippon Life India Asset Management Ltd Ordinary Shares
2.3%
JK Cement Ltd
2.2%
IDFC First Bank Ltd
2.2%
Union Bank of India
2.1%
APL Apollo Tubes Ltd
2.1%
Top industry exposure
Industrials
19.5%
Financial Services
18.4%
Healthcare
15.0%
Consumer Cyclical
14.3%
Basic Materials
7.9%
Other information
Minimum SIP
₹500
Minimum lumpsum
₹1,000
Additional lumpsum
₹1,000
Portfolio turnover
63%
Lock-in period
-
Exit load
• 1% for redemption within 90 days
Fund objective
The investment objective of the Scheme is to seek to generate long term capital appreciation & provide long-term growth opportunities by investing in a portfolio constituted of equity & equity related securities and derivatives predominantly in mid cap companies.
Fund manager(s)
Krishna Sanghavi
Manish Lodha
Kirti Dalvi

FAQs